[ logo.jpg]BioAlliance Pharma SA (Paris:BIO) a specialty pharmaceutical company focused on the treatment of opportunistic infections, in cancer and HIV, today announced the preliminary positive results for its US pivotal Phase III clinical trial wit
Discuss   Add this link to...  Bury

Related Links Who Voted Comments